Miller Howard Investments 13F: Adds $8.7M to CME Stake
Key Points
- Miller Howard Investments raised its position in CME Group by 33,169 shares, a 20.8% increase from the previous total of 159,373 shares.
- Miller Howard Investments held 192,542 $CME shares at quarter end, up 20.81% from the prior quarter.
- The fund's total reported value in CME Group now stands at approximately $50.4 million, representing 4.68% of its overall portfolio.
- CME Group recently traded at about $305.71, slightly below its closing price of $308.06 on the event date.
Get CME Group text alerts
We text you when insiders, Congress, analysts or big funds move on $CME.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated CME Group Inc. alert may contain errors. Disclosures
Miller Howard Investments boosted its stake in CME Group Inc. by 33,169 shares, increasing its total to 192,542 shares valued at about $50.4 million as of October 26, 2026. This change was disclosed in a filing with the SEC on the same date.
CME
CME Group Inc.
Where CME Group Fits in Miller Howard Investments' Portfolio
The CME Group position now represents 4.68% of Miller Howard's total reported value of approximately $1.08 billion, ranking 11th among the fund's 159 holdings.
Other Institutional Activity in CME Group
Sanders Capital, LLC increased its holdings in CME Group by 906,692 shares, bringing its total to 5,067,740 shares valued at approximately $1.56 billion.
CME Group Inc. Stock Down 0.1%
CME Group shares recently traded at about $305.71, which is below the closing price of $308.06 on October 26, 2026. This price point is significant as it reflects a slight dip, about 0.8%, since the filing date.
Recent Earnings
CME Group reported trailing twelve-month revenue of approximately $6.96 billion and an EPS of $12.20. The company has a net margin of 63.5% and a return on equity (ROE) of 16.1%. The next earnings report is scheduled for February 3, 2027.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
2 target cuts vs 0 raises.
-
EPS & revenue
EPS missed estimates by 1.2%. Revenue missed estimates by 1.6%.
-
Profit surprise
EBITDA missed by 6 percent. Operating income missed by 5 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
2 target cuts.
-
Earnings quality
Gross margin up 0.7 points. Operating margin up 2.2 points. Positive free cash flow.
Earnings Call Summary
CME delivered a record first quarter with average daily volume of 36.2 million contracts, up 22 percent year-over-year, marking the highest in company history. Revenue reached $1.88 billion, up 14 percent, with record performance across all six asset classes and international markets. The company achieved record adjusted operating margins of 72.8 percent and adjusted earnings per share of $3.36, returning $3.2 billion to shareholders through dividends and buybacks.
Guidance CME reaffirmed its full-year adjusted expense guidance of about $1.695 billion. The company expects to continue investing in technology and cloud migration while maintaining capital returns through dividends and share buybacks.
Severe negative reset. The report materially damaged the forward outlook and likely forces major downward revisions.
Dividend
CME Group pays an annual dividend rate of $5.20 per share, with a dividend payout ratio of 95.4%.
Insider Buying and Selling at CME Group Inc.
Recently, CEO Terrence A. Duffy sold 15,000 shares on September 10, 2026, valued at about $4.12 million. Director Elizabeth A. Cook sold 500 shares on September 14, 2026, for $140,055. Director William R. Shepard bought 292 shares on September 25, 2026, at an average price of $268.76, totaling $78,626. Director Martin J. Gepsman sold 400 shares on October 22, 2026, valued at $121,000.
Analysts Set New Price Targets
On October 22, 2026, UBS maintained a Neutral rating on CME Group with a price target of $310. Morgan Stanley also maintained an Overweight rating, increasing its target to $359. Barclays kept an Equal-Weight rating with a target of $321, while Wells Fargo and Piper Sandler maintained Overweight ratings with targets of $333 and $330, respectively.
About CME Group
CME Group Inc. operates contract markets for trading futures and options on futures contracts globally. It offers products across various sectors, including interest rates, equity indexes, and commodities. This recent increase in stake by Miller Howard Investments shows confidence in CME's ongoing business performance.
Bottom Line
Investors should keep an eye on CME Group's upcoming earnings report on February 3, 2027, and any further filings from Miller Howard Investments. The fund's recent activity indicates a strategic commitment to CME Group amidst a competitive market landscape.
Related Filing Alerts
Source: Miller Howard Investments's 13F filing on $CME (Oct 26, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Written by software, not financial advice. How we make alerts